An Unusual Case of Opsoclonus-Myoclonus-Ataxia Syndrome Related to Pembrolizumab vs Invasive Ductal Carcinoma
5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB.Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor,
Authors
- Jafar Kafaie
- Wilson Rodriguez
- Laura Polhemus
- Divya Singh (ORCID: https://orcid.org/0000-0002-2961-735X)
- Noah Vermette
- Kyle Polhemus
- Dana Malo
- Brittany Stritar
- Brady Wahlstrom
Publication Details
- Journal
- Neurology
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1212/01.wnl.0001051824.94301.32
- Citations
- 1
- Primary Topic
- Autoimmune Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.37